EUVIMEDEUVIMED entdecken
Open Access

Characterization of cross-reactive, non-neutralizing monoclonal antibodies against a pandemic GII.4 norovirus variant

Lauren A Ford-Siltz iD, Kentaro Tohma iD, Kyle Kihn, Joseph A Kendra iD, Daniel Deredge, Patrick Wintrode, Yamei Gao, Gabriel I Parra iD

Microbiology Spectrum · 2024

DOI: 10.1128/spectrum.01143-24 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Microbiology Spectrum, 2024. Verfasst von Lauren A Ford-Siltz und 7 weiteren Autor:innen. Beteiligte Einrichtung: Division of Viral Products, CBER, FDA, Silver Spring, Maryland, USA. Hauptthemen laut MEDLINE: Norovirus, Antibodies, Monoclonal, Antibodies, Viral, Caliciviridae Infections. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 31 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Antibodies are thought to play a major role in protection against human norovirus infection. Mouse humoral responses closely mimic those of humans; thus, mouse models are used to characterize norovirus epitopes on the major viral capsid protein, VP1. We have developed a panel of mouse monoclonal antibodies (mAbs) produced against the last pandemic variant to emerge, Sydney 2012. While most mAbs (25/44) were mapped to variable antigenic sites on VP1, 19 of the mAbs were cross-reactive against multiple genotypes or GII.4 variants. Most (12/19) of the cross-reactive mAbs bound to the Shell domain and were cross-reactive with different GII noroviruses. Interestingly, mAb 30A11 exhibited cross-reactivity against all tested norovirus genotypes (GI, GII, GIV, and GIX). This mAb was mapped to a highly conserved region of the Shell domain ( 51 PIDPWII 57 ) using peptide ELISA and immunofluorescence. Of those mapping to the Protruding (P) domain, two (19C10 and 14B11) showed cross-reactivity with GII noroviruses. Using hydrogen-deuterium exchange mass spectrometry, we mapped 19C10 to a conserved region of the P domain near the P/Shell interface, which explains its cross-reactivity with different GII noroviruses and lack of histo-blood group antigen-blocking activity. Binding and mutational analyses showed that residues 518, 519, and 525 are important for 19C10 and 14B11 epitope recognition. While the antibodies described here are mostly non-neutralizing, they can be useful tools for research and diagnostics of noroviruses. The role of non-neutralizing, cross-reactive antibodies targeting different areas of the viral capsid merits further research to facilitate our understanding of immunity to norovirus infection and disease. IMPORTANCE To gain insights into the overall immune responses to human norovirus, we characterized non-neutralizing, cross-reactive monoclonal antibodies (mAbs) developed against a pandemic GII.4 norovirus. We determined the binding epitope of an antibody that exhibited cross-reactivity against all tested noroviruses, which makes it a useful tool for research and diagnostics. The epitope of two additional non-neutralizing mAbs was mapped to a less conserved region on the viral capsid protein, explaining their cross-reactivity patterns. Often overlooked, the role of non-neutralizing, cross-reactive mAbs merits further research to facilitate our understanding of immunity to norovirus infection and disease.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NorovirusAntibodies, MonoclonalAntibodies, ViralCaliciviridae InfectionsCross ReactionsAnimalsMiceHumansCapsid ProteinsEpitopesEpitope MappingGenotypeAntibodies, NeutralizingMice, Inbred BALB CPandemics

Stichwörter der Autor:innen

GII.4 noroviruscross-reactive antibodiesmonoclonal antibodies

Substanzen

Antibodies, MonoclonalAntibodies, ViralCapsid ProteinsEpitopesAntibodies, Neutralizing

Autor:innen und Institutionen

  • Division of Viral Products, CBER, FDA, Silver Spring, Maryland, USA.
  • University of Maryland School of Pharmacy, Baltimore, Maryland, USA.

ORCID-Profile: Lauren A Ford-Siltz, Kentaro Tohma, Joseph A Kendra, Gabriel I Parra

Zitieren

APA

Ford-Siltz, L. A., Tohma, K., Kihn, K., Kendra, J. A., Deredge, D., Wintrode, P., Gao, Y., & Parra, G. I. (2024). Characterization of cross-reactive, non-neutralizing monoclonal antibodies against a pandemic GII.4 norovirus variant. Microbiology Spectrum. https://doi.org/10.1128/spectrum.01143-24

Vancouver

Ford-Siltz LA, Tohma K, Kihn K, Kendra JA, Deredge D, Wintrode P, et al. Characterization of cross-reactive, non-neutralizing monoclonal antibodies against a pandemic GII.4 norovirus variant. Microbiology Spectrum. 2024. doi:10.1128/spectrum.01143-24

BibTeX
@article{FordSiltz2024,
  author = {Ford-Siltz, Lauren A and Tohma, Kentaro and Kihn, Kyle and Kendra, Joseph A and Deredge, Daniel and Wintrode, Patrick and Gao, Yamei and Parra, Gabriel I},
  title = {Characterization of cross-reactive, non-neutralizing monoclonal antibodies against a pandemic GII.4 norovirus variant},
  journal = {Microbiology Spectrum},
  year = {2024},
  doi = {10.1128/spectrum.01143-24}
}
Kostenlos starten →